General Information |
|
| NSE Symbol* | LALPATHLAB |
| Name of the Company* | DR. LAL PATH LABS LTD. |
| ISIN* | INE600L01024 |
| Type of Meeting |
1) Board Meeting |
| Details of Committee Meeting or Other Type of Meeting | |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-04-25 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-04-01 |
| Details of Trading Window Closure End date | 2025-04-27 |
| Short Notice | |
| Date of Report* | 2025-04-18 |
Agenda Details |
|
| Agenda* |
1) Financial results 2) Dividend 3) Other business |
| Whether results are audited or unaudited | Audited |
| Nature of report standalone or consolidated | Standalone And Consolidated |
| Period end Type | Yearly |
| Period up to (Month) | March |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend |
1) Final |
| Remarks (website dissemination) | The meeting of the Board of Directors is scheduled to be held on Friday, April 25, 2025 to inter-alia consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31, 2025 and to consider recommending Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended March 31, 2025. |